Evidence map›Paper›PMID 22778868›Full record

ArticleACS chemical neuroscience2011

Molecular engineering of a secreted, highly homogeneous, and neurotoxic aβ dimer.

Andreas Müller-Schiffmann, Aksana Andreyeva, Anselm H C Horn, Kurt Gottmann, Carsten Korth, Heinrich Sticht

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease AssociatedInternational journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
  7. Conformational Ensembles of the Wild-Type and S8C Aβ1-42 Dimers.The journal of physical chemistry. B · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Glial cells in (patho)physiology.Journal of neurochemistry · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andreas Müller-SchiffmannDepartment of Neuropathology, Heinrich Heine University, Düsseldorf, Germany.
Aksana Andreyeva
Anselm H C Horn
Kurt Gottmann
Carsten Korth
Heinrich Sticht

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aβ oligomers play a key role in the pathophysiology of Alzheimer's disease. Research into structure-function relationships of Aβ oligomers has been hampered by the lack of large amounts of homogeneous and stable material. Using computational chemistry, we designed conservative cysteine substitutions in Aβ aiming at accelerating and stabilizing assembly of Aβ dimers by an intermolecular disulfide bond without changing its folding. Molecular dynamics simulations suggested that mutants AβS8C and AβM35C exhibited structural properties similar to those of Aβ wildtype dimers. Full length, mutant APP was stably expressed in transfected cell lines to study assembly of Aβ oligomers in the physiological, secretory pathway and to avoid artifacts resulting from simultaneous in vitro oxidation and aggregation. Biochemical and neurophysiological analysis of supernatants indicated that AβS8C generated an exclusive, homogeneous, and neurotoxic dimer, whereas AβM35C assembled into dimers, tetramers, and higher oligomers. Thus, molecular engineering enabled generation of bioactive, homogeneous, and correctly processed Aβ dimers in vivo.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesCell LineComputational BiologyCysteineDimerizationHumansMutationTransfectionAmyloid beta-PeptidesCysteineAlzheimer’s diseaseAβ oligomerscomputational chemistrydimersmolecular engineeringneurotoxicity

Identifiers

PMID22778868
PMCPMC3369749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.